Encompass Health is a medical care facilities business based in the US. Encompass Health shares (EHC) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $98.85 – a decrease of 4.22% over the previous week. Encompass Health employs 27,481 staff and has a trailing 12-month revenue of around $5.2 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $98.85 |
|---|---|
| 52-week range | $63.29 - $104.55 |
| 50-day moving average | $96.24 |
| 200-day moving average | $86.32 |
| Wall St. target price | $115.25 |
| PE ratio | 24.1551 |
| Dividend yield | $0.62 (0.66%) |
| Earnings per share (TTM) | $4.19 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $98.85 from 2024-11-15
| 1 week (2024-11-08) | -4.22% |
|---|---|
| 1 month (2024-10-17) | 2.02% |
| 3 months (2024-08-16) | 11.54% |
| 6 months (2024-05-17) | 15.68% |
| 1 year (2023-11-17) | 53.66% |
|---|---|
| 2 years (2022-11-17) | 81.84% |
| 3 years (2021-11-17) | 60.68% |
| 5 years (2019-11-15) | 50.82% |
Valuing Encompass Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Encompass Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Encompass Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Encompass Health shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Encompass Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 billion.
The EBITDA is a measure of a Encompass Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $5.2 billion |
|---|---|
| Operating margin TTM | 15.48% |
| Gross profit TTM | $1.8 billion |
| Return on assets TTM | 8.38% |
| Return on equity TTM | 22.92% |
| Profit margin | 8.1% |
| Book value | $19.44 |
| Market Capitalization | $10.2 billion |
TTM: trailing 12 months
Dividend payout ratio: 14.73% of net profits
Recently Encompass Health has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Encompass Health shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Encompass Health's case, that would currently equate to about $0.62 per share.
While Encompass Health's payout ratio might seem low, this can signify that Encompass Health is investing more in its future growth.
Encompass Health's most recent dividend payout was on 14 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 1 January 2025 (the "ex-dividend date").
Encompass Health's shares were split on a 1257:1000 basis on 30 June 2022 . So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1257 shares. This wouldn't directly have changed the overall worth of your Encompass Health shares – just the quantity. However, indirectly, the new 20.4% lower share price could have impacted the market appetite for Encompass Health shares which in turn could have impacted Encompass Health's share price.
Over the last 12 months, Encompass Health's shares have ranged in value from as little as $63.2874 up to $104.55. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Encompass Health's is 0.78. This would suggest that Encompass Health's shares are less volatile than average (for this exchange).
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama. .
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.